CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Interview
CREST Trial Shows CAS and CEA To Be Comparable Therapies for Stroke Prevention
Q: What do you anticipate the CREST results will show?
Rosenfield: CREST (Carotid Revascularization Endarterectomy versus Stent Trial) is a landmark trial which shows that endarterectomy and stenting for carotid artery stenosis appear to be comparable based on the primary endpoint of the trial: death, stroke and myocardial infarction. Both carotid artery stenting (CAS) and carotid endarterectomy (CEA) had remarkably low event rates and were shown to be very safe and effective stroke prevention therapies. It should be noted that this is the largest (2,52
The Mo.Ma® Ultra Proximal Cerebral Protection Device: An Effective New Tool
Interview with Co-Principal Investigators of the ARMOUR Trial: Gary Ansel, MD and L. Nelson Hopkins, MD
What was the purpose and scope of the ARMOUR trial? What were the trial’s
primary and secondary end points?
ANSEL: The purpose of the trial was to test a proximal protection device for carotid artery stenting (CAS) called the Mo.Ma® Ultra Proximal Cerebral Protection Device (Invatec, Inc., Bethlehem, Pennsylvania). This is a flow-clamping device to allow for CAS. The primary endpoints were MACE, which included any myocardial inf
Purcutaneous Intraspinal Navigation (PIN)
What is PIN?
PIN stands for percutaneous intraspinal navigation. Just as we’ve been using the arteries as a conduit to navigate the vascular system for a long time, we also believe it may be possible to use the space surrounding the brain and spinal cord — the so-called sub-arachnoid space — to navigate in and around the brain and spinal cord. We've known for a long time that you can access that space by putting a needle in the back. Currently, people visualize the spinal cord via myelograms and also perform lumbar punctures to draw some of the spinal fluid. Another way that peop
Vascular Disease Management talks with one of the course directors, David E. Allie, MD. 2005 marks the sixth year of this multi-
The First International CLI Summit on Lower Extremity PVD and Critical Limb Ischemia
A Pre New Cardiovascular Horizons Event
October 26-27, 2005, New Orleans Marriott, New Orleans, Louisiana
www.clisummit.com
New Cardiovascular Horizons and Management of the Diabetic Foot & Wound Healing
October 27-29, 2005, New Orleans Marriott, New Orleans, Louisiana
www.newcvhorizons.com
Can you tell us about the history and philosophy behind the New Cardiovascular Horizons meeting?
New Cardiovascular Horizons (NCVH) began in 2000 as a small, local, multi-dis
The 13th Annual Global Cardiovascular Interventions–New Devices Seminar
Dr. Mark H. Wholey
What would you like to share with the physician or professional who has never had the chance to attend the New Devices Seminar?
The New Devices Seminar is a meeting we have had for approximately 12 years now, on an annual basis. It is designed for physicians interested in peripheral vascular disease, but also coronary artery disease as well.
A blue-ribbon faculty presents cases and discusses concepts in management of complex and simple cases. With the expansion of interest from cardiologists and vascular surgeons in endovascular peripheral procedures, it
Recognizing Expertise: Obtaining Certification by the American Board of Vascular Medicine
Why do you think this board is of value to the field of endovascular medicine?
Right now, there aren’t enough experts in vascular medicine to care for the masses of patients who have systemic atherosclerosis. So many different specialists are involved in the care of these patients that it’s hard to know who really has expertise in the overall management of patients with vascular disease. The concept behind the creation of the American Board of Vascular Medicine is to set a standard level so that people who have really dedicated themselves to the management of these patients and to
Integral Components of a Comprehensive Program to Treat Carotid Artery Disease
Can you talk about the value of a comprehensive clinical program for the treatment of carotid artery disease (CAD)? How important is a thorough body of evidence?
A rigorous clinical program for the treatment of CAD provides physicians with a foundation of clinical evidence to guide the selection of an appropriate treatment strategy for each patient. It also provides the resources, such as training programs, that consolidate this information and help physicians execute treatment plans. The majority of treatments for CAD over the past 50 years were not based on evidence from controll
It’s Still On! Now in Miami Beach, Florida! The First International CLI Summit on Lower Extremity PVD and Critical Limb Ischemi
In lieu of the horrible events that have recently occurred in New Orleans due to Hurricane Katrina, what is the current status of the national New Cardiovascular Horizons, Renaissance Summit, and CLI Summit meetings?
In the face of the single largest natural disaster that this country has ever experienced, it is hard to focus on anything 6–8 weeks from now, especially something educational and not life-or-death. But we must. Life goes on, and so does education. Some hard decisions had to be made. In the true spirit of education, the executive committees of all three events have adopt
Cyroplasty in the Treatment of Infrainguinal Arterial Disease: An Interview with James Joye, DO
Many physicians are exploring device use in the lower extremities, while techniques for successful and appropriate stenting are also being intensely discussed. Where does cryoplasty fit into the current picture?
Peripheral vascular disease, in general, is a relentless and proliferative process. With cryoplasty, whether it be in the fem-pop segment or below the knee, we are trying to achieve both better acute outcomes and long-term outcomes. What we're trying to accomplish is a minimization of the need for stent implants in the legs because they have their own set of problems and simu
Measuring the Efficacy of CryoPlasty
Q. What is CryoPlasty® Therapy?
A. In CryoPlasty® Therapy, nitrous oxide is used to fill an angioplasty balloon within a blocked artery, cooling the balloon’s surface to -10° C. As the balloon is inflated, its cold surface cools the lesion, which exerts both mechanical and biological effects that may help prevent re-blockage of the artery (Figure 2).
Q. Can you describe the Below-The-Knee (BTK) CHILL study?
A. BTK CHILL was a prospective, multi-center study designed to evaluate the technical effectiveness and limb salvage potential of C
Vascular Disease Blogs
Robert S. Dieter, MD, RVT and Aravinda Nanjundappa, MD, RVT
VDM Monthly Poll
Digital Supplements
Terumo Clinical Case Update This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.
Vascular Disease News Wire
- Monday, March 1, 2010 - 22:25
- Sunday, February 28, 2010 - 20:53
- Friday, February 26, 2010 - 10:50
Anytown, California
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.
